SeterusnyaPanduan seterusnya
AI Medication Error Prevention
industri
PANDUAN Industri
AI in pharmacy medication adherence programs predicts which patients are likely to stop or delay their chronic medicines, then points pharmacists toward targeted outreach, refill synchronization and other fixes before gaps appear.
Dengar panduan iniAI-diceritakan · ~3 min
It matters because nonadherence weakens treatment for conditions such as diabetes, hypertension and high cholesterol. In the US, Medicare Part D Star Ratings also include adherence measures that affect health plans and their pharmacy networks.
Adherence is usually measured from pharmacy claims, not by watching patients take pills. The most common metric is proportion of days covered (PDC): the share of days in a period on which the patient had medicine on hand, based on fill dates and days supplied. A PDC of 80 percent or more is the usual threshold for counting a patient as adherent. The Pharmacy Quality Alliance develops widely used adherence measures. Medicare Part D Star Ratings include adherence measures for non-insulin diabetes medicines, renin-angiotensin system antagonists and statins, and these have carried substantial weight in plan ratings. As a result, plans reward pharmacies that improve these numbers. Prediction models use signals such as prior fill history, whether a drug is newly started, copay, number of medicines, pharmacy changes, recent hospital stays and late first refills. Their job is to decide who gets limited pharmacist time. The interventions matter more than the prediction. Medication synchronization, sometimes called the appointment-based model, lines refills up to one date and adds a regular check-in. Other interventions include 90-day supplies, delivery, simpler regimens, help with cost and conversations about side effects or beliefs. Two misconceptions are common. First, a refill does not prove the patient took the medicine. PDC measures possession, and automatic refills can raise PDC without changing behavior. Second, the patients with the highest risk are not always the best ones to contact. Some would stop regardless, and others would refill without help. The goal is to reach patients whose behavior outreach can actually change.
A model flags a patient who just started a statin, has a high copay and has never taken a chronic medicine before as unlikely to refill. A pharmacist calls about ten days in to ask about side effects and cost.
A pharmacy enrolls a patient taking five chronic medicines in medication synchronization. All refills come due on one pickup date, and a call each month checks for dose changes before filling.
A Part D plan's dashboard lists members whose proportion of days covered for renin-angiotensin system antagonists is falling below 80 percent but who still have enough days left in the year to recover.
For a patient with transport problems who keeps missing pickups, the pharmacist suggests a 90-day supply or home delivery.
Adherence programs will likely keep improving targeting and linking outreach to the reasons patients stop, such as cost, side effects or pickup barriers, rather than sending the same reminders to everyone. Changes to how Star Ratings weight measures, and to Medicare drug cost rules, will shape how much plans invest, so follow official CMS announcements rather than assumptions. Language-model assistants may help draft outreach and summarize calls. Whether programs improve clinical outcomes, not just PDC, is still the key question for well-designed studies.
Newsletter percuma
Tiga cerita AI yang disahkan setiap pagi hari bekerja, ditulis dalam Bahasa Inggeris biasa. Percuma selamanya, tiada iklan.
Satu e-mel setiap hari bekerja. Berhenti melanggan dalam satu klik. Kami tidak pernah menjual atau berkongsi alamat anda.
Uji diri anda
Maklum balas segera pada setiap jawapan, dan sijil yang boleh dikongsi dengan ID yang boleh disahkan sebaik sahaja anda lulus kursus.
Sokong pendidikan AI percuma. AI Understanding ialah pertubuhan bukan keuntungan 501(c)(3) — tiada iklan, tiada bayaran dinding, selamanya. Buat derma
AI in pharmacy medication adherence programs predicts which patients are likely to stop or delay their chronic medicines, then points pharmacists toward targeted outreach, refill synchronization and other fixes before gaps appear. It matters because nonadherence weakens treatment for conditions such as diabetes, hypertension and high cholesterol. In the US, Medicare Part D Star Ratings also include adherence measures that affect health plans and their pharmacy networks.
PDC dikira dari tarikh pengisian dan hari yang dibekalkan, jadi ia mengukur pemilikan, tidak diperhatikan secara langsung pengambilan pil.
Langkah pematuhan Bahagian D meliputi ubat diabetes bukan insulin, antagonis sistem renin-angiotensin dan statin.
Panduan memberikan 80 peratus atau lebih sebagai ambang pematuhan biasa.
Kerana PDC mengukur pemilikan, pengisian secara automatik boleh meningkatkan bilangan walaupun pesakit tidak mengambil ubat.
Pemodelan peningkatan menganggarkan kesan rawatan jangkauan, jadi ahli farmasi menghabiskan masa untuk pesakit yang tingkah lakunya boleh berubah.
Teruskan belajar
Lebih banyak panduan dipilih untuk topik ini
SeterusnyaPanduan seterusnya
AI Medication Error Prevention
industri